Literature DB >> 3921624

Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice.

I A Bakker-Woudenberg, A F Lokerse, F H Roerdink, D Regts, M F Michel.   

Abstract

Efficacy of liposomal as compared with free ampicillin in treatment of infection due to Listeria monocytogenes was studied in normal and congenitally athymic (nude) mice. After intravenous injection the multilamellar vesicles used were taken up mainly by liver and spleen, the target organs of L. monocytogenes. Injection of empty liposomes in two doses of 2 mumol of vesicle lipid each, administered at 40 and 112 hr after bacterial inoculation, did not influence the course of listerial infection in normal and nude mice. In normal mice liposomal entrapment of ampicillin resulted in significant improvement in the antibiotic's therapeutic index. The use of liposomal ampicillin at a total dose of 0.54 mg (two doses of 0.27 mg each) resulted in a therapeutic effect similar to that resulting from a total dose of 48 mg of free ampicillin (eight doses of 6 mg each). However, neither ampicillin treatment schedules cured infections in nude mice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921624     DOI: 10.1093/infdis/151.5.917

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.

Authors:  S Majumdar; D Flasher; D S Friend; P Nassos; D Yajko; W K Hadley; N Düzgüneş
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

3.  Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

Authors:  E W van Etten; M T ten Kate; S V Snijders; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

4.  Inhibition of tracheal vascular extravasation by liposome-encapsulated albuterol in rats.

Authors:  W Zhang; L Guo; J A Nadel; D Papahadjopoulos
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

Review 5.  Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience.

Authors:  A Coune
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 6.  Management of listeriosis.

Authors:  H Hof; T Nichterlein; M Kretschmar
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

7.  Liposomes in chemo- and immunotherapy of cancer.

Authors:  G L Scherphof; T Daemen; H H Spanjer; F H Roerdink
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

Review 8.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

Review 9.  Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

Authors:  G Gregoriadis; A T Florence
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

Review 10.  Liposomes and nanoparticles in the treatment of intracellular bacterial infections.

Authors:  P Couvreur; E Fattal; A Andremont
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.